FindTrial
Sign In

prophylactic donor lymphocyte infusion after stem cell transplant for refractory/relapsed leukemia - a randomized, controlled, clinical trial

prophylactic donor lymphocyte infusion after stem cell transplant for refractory/relapsed leukemia - a randomized, controlled, clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002237
Enrollment
Unknown
Registered
2012-06-05
Start date
2012-06-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia

Interventions

trial group:prophylactic DLI
control group:without prophylactic DLI

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. refractory/relapsed leukemia undergoing HSCT; 2. remaining in CR one month after HSCT; 3. without GVHD or GVHD controlled, without severe infection, without organ failure within 30-60d post HSCT.

Exclusion criteria

Exclusion criteria: 1. active GVHD; 2. uncontrolled infection; 3. organ failure; 4. early relapse or death.

Design outcomes

Primary

MeasureTime frame
relapse rate;—

Countries

China

Contacts

Public ContactHuang Xiao-jun
huangxiaojun@bjmu.edu.cn+86 10 88326006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026